Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood.
about
Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infectionsModulation of neutrophil function by a secreted mucinase of Escherichia coli O157:H7Antineutrophil cytoplasm antibodies and vasculitisCXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation.Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality.Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome.Cytokine expression in the renal tubular epithelial cells stimulated by Shiga toxin 2 of Escherichia coli O157:H7.Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome.Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia.The functional state of neutrophils correlates with the severity of renal dysfunction in children with hemolytic uremic syndrome.Synergistic interactions between interferon-gamma and TRAIL modulate c-FLIP in endothelial cells, mediating their lineage-specific sensitivity to thrombotic thrombocytopenic purpura plasma-associated apoptosisShiga toxin pathogenesis: kidney complications and renal failure.Cytokines in haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infection.Advances in haemolytic uraemic syndrome.Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome.Chemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and/or lipopolysaccharidesLipopolysaccharide renders transgenic mice expressing human serum amyloid P component sensitive to Shiga toxin 2Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis.Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration.Reduced virulence of an fliC mutant of Shiga-toxigenic Escherichia coli O113:H21.The significance of interleukin 8 in urine.Nitric oxide inhibits Shiga-toxin synthesis by enterohemorrhagic Escherichia coliEnhanced CXC chemokine responses of human colonic epithelial cells to locus of enterocyte effacement-negative shiga-toxigenic Escherichia coliShiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinibActivation of the Akt-NF-kappaB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response.Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes.The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety?Shiga toxin 1 causes direct renal injury in rats.Flagellin Induces β-Defensin 2 in Human Colonic Ex vivo Infection with Enterohemorrhagic Escherichia coli.Molecular damage and induction of proinflammatory cytokines in human endothelial cells exposed to Shiga toxin 1, Shiga toxin 2, and alpha-sarcin
P2860
Q24550740-2B77C835-7947-4D0B-B18D-511777749BD9Q27317705-B10331D2-1486-4C42-9D2A-F72B36760C2EQ27477816-E2888F56-3BC8-461F-BE29-B2ADBBF0B940Q30442733-2788AAC7-9A4F-4CD0-9AA8-C49B26E98457Q33331011-79A7CFCF-2FF1-4E99-8AF0-07C62665EBE1Q33338331-67CD4E11-72AC-4EFF-AC1F-C34C19C17E1CQ33344709-AB64260E-48A6-4A4A-B70E-0F0ED4868C46Q33345355-797F032F-33A3-4C45-8F63-518B4156D475Q33372623-8061924F-F406-427F-AE04-070375C1B50CQ33373797-8FD290E8-96ED-48CB-AE03-52CCC357919BQ33378957-993DB20B-E6E3-45AB-8723-AB3AF3C32A8EQ33397541-CE996860-AE11-487B-92F0-DCEAA98FCC16Q33500346-0CB2A486-030C-4BC1-B4F0-58DA4406545AQ33502399-1BECD255-6A80-46FC-89C1-68E91DC4C70FQ33502724-1489D088-309B-449D-AB95-B76FA9D8563FQ33557728-5EC9712C-F180-4224-AD17-6B1DD77AB771Q33952458-DA066D21-CB59-4B85-8818-CF336348AB5CQ34000714-24C21E5B-5299-4E5E-A374-52912B3119C8Q34009274-C92014BB-13C1-4407-81AD-AE234A14A3DCQ34491859-568BD63E-5410-46AD-A457-37442F0E6B69Q35271086-1D01B49A-52FA-4A20-A511-AA026D3C9F95Q35840558-9ECF6163-06D4-4795-86F3-9C6B98FC32D6Q36044254-6DAC147A-CE7D-4DD5-88DC-59F99226DBBCQ36382092-BCDC5388-B237-4E95-8696-F14E02AF5F9BQ37389501-36695489-F690-4C37-9466-E562CAE248AEQ37582841-13EF964D-BDCA-49DE-B6AC-616B18694B62Q38022246-BFC0CC22-6DC8-4828-951C-786DAB9555DAQ39392213-BEF84D4D-37A5-4365-8E8F-354F5BC12027Q40603856-E4C03B6B-6463-45A7-99D8-6E359AC18B0CQ41873961-F89E29CD-AB5A-4047-B141-94623C5E1555
P2860
Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood.
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Interleukin-8 and polymorphone ...... uremic syndrome of childhood.
@ast
Interleukin-8 and polymorphone ...... uremic syndrome of childhood.
@en
type
label
Interleukin-8 and polymorphone ...... uremic syndrome of childhood.
@ast
Interleukin-8 and polymorphone ...... uremic syndrome of childhood.
@en
prefLabel
Interleukin-8 and polymorphone ...... uremic syndrome of childhood.
@ast
Interleukin-8 and polymorphone ...... uremic syndrome of childhood.
@en
P2093
P356
P1433
P1476
Interleukin-8 and polymorphone ...... uremic syndrome of childhood.
@en
P2093
Barratt TM
Fitzpatrick MM
Trompeter RS
P2888
P304
P356
10.1038/KI.1992.372
P407
P577
1992-10-01T00:00:00Z
P5875
P6179
1012265669